References
- Finnerup NB, Otto M, McQuay H, et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005;118:289–305.
- Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain. 2010;150:573–581.
- Ueda H. Molecular mechanisms of neuropathic pain–phenotypic switch and initiation mechanisms. Pharmacol Ther. 2006;109:57–77.
- Schestatsky P, Vidor L, Winckler PB, et al. Promising treatments for neuropathic pain. Arq Neuropsiquiatr. 2014;72:881–888.
- Jaggi AS, Jain V, Singh N. Animal models of neuropathic pain. Fundam Clin Pharmacol. 2011;25:1–28.
- Kaur M, Singh A, Kumar B, et al. Protective effect of co-administration of curcumin and sildenafil in alcohol induced neuropathy in rats. Eur J Pharmacol. 2017;805:58–66.
- Bansode VJ, Vyawahare NS, Munjal NB, et al. Ameliorative effect of ethyl pyruvate in neuropathic pain induced by chronic constriction injury of sciatic nerve. Indian J Pain. 2014;28:82.
- Bridges D, Thompson S, Rice A. Mechanisms of neuropathic pain. Br J Anaesth. 2001;87:12–26.
- Chaplan SR, Bach F, Pogrel J, et al. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994;53:55–63.
- Yoon C, Wook YY, Sik NH, et al. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain. 1994;59:369–376.
- Cohen SP, Mao J. Neuropathic pain: mechanisms and their clinical implications. Bmj. 2014;348:1–12.
- Huang LJ, Yoon MH, Choi JI, et al. Effect of sildenafil on neuropathic pain and hemodynamics in rats. Yonsei Med J. 2010;51:82–87.
- Colloca L, Ludman T, Bouhassira D, et al. Neuropathic pain. Nat Rev Dis Primers. 2017;3:17002.
- Dworkin RH, O’connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clinic Proceedings; Elsevier, 2010;85(3 Suppl):S3–14. doi:10.4065/mcp.2009.0649.
- Gangadhar M, Kumar Mishra R, Sriram D, et al. Future directions in the treatment of neuropathic pain: a review on various therapeutic targets. CNS & Neurol Disord Drug Targets. 2014;13:63–81.
- Hahm T, Ahn H, Ryu S, et al. Combined carbamazepine and pregabalin therapy in a rat model of neuropathic pain. Br J Anaesth. 2012;109:968–974.
- Dale DJ, Dunn PJ, Golightly C, et al. The chemical development of the commercial route to sildenafil: a case history. Org Process Res Dev. 2000;4:17–22.
- Roustit M, Cracowski J-L. Assessment of endothelial and neurovascular function in human skin microcirculation. Trends Pharmacol Sci. 2013;34:373–384.
- Puzzo D, Sapienza S, Arancio O, et al. Role of phosphodiesterase 5 in synaptic plasticity and memory. Neuropsychiatr Dis Treat. 2008;4:371.
- Charriaut-Marlangue C, Nguyen T, Bonnin P, et al. Sildenafil mediates blood-flow redistribution and neuroprotection after neonatal hypoxia-ischemia. Stroke. 2014;45:850–856.
- Nguyen VA, Le T, Tong M, et al. Experimental alcohol-related peripheral neuropathy: role of insulin/IGF resistance. Nutrients. 2012;4:1042–1057.
- Kim WM, Yoon MH, Lee HG, et al. GABAB receptor modulation on the antinociception of intrathecal sildenafil in the rat formalin test. Korean J Pain. 2007;20:106–110.
- Chen M, Hoshino H, Saito S, et al. Spinal dopaminergic involvement in the antihyperalgesic effect of antidepressants in a rat model of neuropathic pain. Neurosci Lett. 2017;649:116–123.
- Treede R-D, Jensen TS, Campbell J, et al. Neuropathic pain redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630–1635.
- De Vry J, Kuhl E, Franken-Kunkel P, et al. Pharmacological characterization of the chronic constriction injury model of neuropathic pain. Eur J Pharmacol. 2004;491:137–148.
- Austin PJ, Moalem-Taylor G. The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. J Neuroimmunol. 2010;229:26–50.
- Austin PJ, Wu A, Moalem-Taylor G. Chronic constriction of the sciatic nerve and pain hypersensitivity testing in rats. J Vis Exp. 2012.
- Bennett GJ, Xie Y-K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988;33:87–107.
- Muthuraman A, Singh N. Attenuating effect of Acorus calamus extract in chronic constriction injury induced neuropathic pain in rats: an evidence of anti-oxidative, anti-inflammatory, neuroprotective and calcium inhibitory effects. BMC Complement Altern Med. 2011;11:24.
- Muthuraman A, Singh N. Neuroprotective effect of saponin rich extract of Acorus calamus L. in rat model of chronic constriction injury (CCI) of sciatic nerve-induced neuropathic pain. J Ethnopharmacol. 2012;142:723–731.
- Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–275.
- Grisham MB, Specian RD, Zimmerman TE. Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis. J Pharmacol Exp Ther. 1994;271:1114–1121.
- Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82:70–77.
- George A, Schmidt C, Weishaupt A, et al. Serial determination of tumor necrosis factor-alpha content in rat sciatic nerve after chronic constriction injury. Exp Neurol. 1999;160:124–132.
- Sudoh Y, Desai SP, Haderer AE, et al. Neurologic and histopathologic evaluation after high-volume intrathecal amitriptyline. Reg Anesth Pain Med. 2004;29:434–440.
- Raputova J, Srotova I, Vlckova E, et al. Sensory phenotype and risk factors for painful diabetic neuropathy: a cross-sectional observational study. Pain. 2017;158:2340.
- Khan J. Neuropathic pain. J Indian Prosthodontic Soc. 2016;16:114.
- Baron R. Mechanisms of disease: neuropathic pain—a clinical perspective. Nat Clin Pract Neurol. 2006;2:95–106.
- Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 1999;353:1959–1964.
- Quintans JS, Antoniolli ÂR, Almeida JR, et al. Natural products evaluated in neuropathic pain models‐a systematic review. Basic Clin Pharmacol Toxicol. 2014;114:442–450.
- Rasoulian B, Hajializadeh Z, Esmaeili-Mahani S, et al. Neuroprotective and antinociceptive effects of rosemary (Rosmarinus officinalis L.) extract in rats with painful diabetic neuropathy. J Physiol Sci. 2019;69:57–64.
- Birmann PT, Sousa FS, Domingues M, et al. 3-(4-Chlorophenylselanyl)-1-methyl-1H-indole promotes recovery of neuropathic pain and depressive-like behavior induced by partial constriction of the sciatic nerve in mice. J Trace Elem Med Biol. 2019;54:126–133. doi:10.1016/j.jtemb.2019.04.014.
- Berge OG. Predictive validity of behavioural animal models for chronic pain. Br J Pharmacol. 2011;164:1195–1206.
- Aston-Jones G. Compositions and methods for treating neuropathic pain. Google Pat. 2019. United States Patent Application Publication. Publication no. US 2015 0141451A1.
- Yoon M, Kim Y, Huang L. Antinociceptive effect of intravenous sildenafil in a neuropathic pain rat model. J Pain. 2009;10:S30.
- Sawynok J, Esser M, Reid A. Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat. Pain. 1999;82:149–158.
- Wattiez A-S, Dupuis A, Privat A-M, et al. Disruption of 5-HT2A-PDZ protein interaction differently affects the analgesic efficacy of SSRI, SNRI and TCA in the treatment of traumatic neuropathic pain in rats. Neuropharmacology. 2017;125:308–318.
- Alboghobeish S, Naghizadeh B, Kheirollah A, et al. Fluoxetine increases analgesic effects of morphine, prevents development of morphine tolerance and dependence through the modulation of L-type calcium channels expression in mice. Behav Brain Res. 2019;361:86–94.
- Mbiantcha M, Khalid R, Dawe A, et al. Antihypernociceptive and neuroprotective effects of Combretin A and Combretin B on streptozotocin-induced diabetic neuropathy in mice. Naunyn-Schmiedeberg’s Arch Pharmacol. 2019;392(6):697–713. doi:10.1007/s00210-019-01626-1.
- Barakat A, Hamdy MM, Elbadr MM. Uses of fluoxetine in nociceptive pain management: a literature overview. Eur J Pharmacol. 2018;829:12–25.
- Murad H, Ayuob N. Co-administration of pioglitazone improves fluoxetine’s antinociceptive, neuroprotective, and antidepressant effects in chronic constriction injury in rats. Pain Physician. 2015;18:609–620.
- Bender G, Florian JA, Bramwell S, et al. Pharmacokinetic–pharmacodynamic analysis of the static allodynia response to pregabalin and sildenafil in a rat model of neuropathic pain. J Pharmacol Exp Ther. 2010;334:599–608.
- Yoon MH, Kim CM, Lee HG, et al. Synergistic antinociception of intrathecal sildenafil with clonidine in the rat formalin test. Pharmacol Biochem Behav. 2009;92:583–588.